Detalhe da pesquisa
1.
A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial.
BMC Infect Dis
; 20(1): 524, 2020 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32689975
2.
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
Lancet Haematol
; 5(5): e190-e200, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703335
3.
Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatment.
Oncotarget
; 8(39): 64999-65008, 2017 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029407